Follow Us:

AUSTRALIA

  • FDA Approves Duchenne Muscular Dystrophy Drug

    Asian Scientist Newsroom | September 29, 2016 | Pharma

    Scientists in Australia had originally developed Eteplirsen®, a drug that treats a rare and fatal muscle-wasting disease affecting one in 3,500 boys worldwide.

MORE NEWS FROM Australia

Subscribe to our newsletter